ArticleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2025
Quebec French Version of the Hayling Sentence Completion Test: Error Scoring Guidelines, Normative Data for Adults and the Elderly and Validation Study in Mild Cognitive Impairment and Alzheimer's Disease.
Article in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionDeficits in inhibition have been associated with various clinical conditions, including neurodegenerative diseases. The Hayling Sentence Completion Test (HSCT) is an assessment tool commonly used in clinical settings to measure verbal initiation and prepotent verbal response inhibition. Although it is used by numerous clinical and research groups in Quebec, normative data for the HSCT are not yet available for French-Quebec speakers.
objectivesThe aims of this study were to provide error scoring guidelines and normative data in the adult population of French Quebec for the HSCT-QC (Study 1) and to determine its known-group discriminant validity (Study 2).
resultsThe results of Study 1, based on a sample of 214 healthy individuals aged 50 to 89, indicated that age significantly affected test performance, while educational level and sex did not. As no transformations were able to normalize the score distribution, percentile ranks for HSCT-QC performance were calculated solely based on age. Results from Study 2 demonstrated that the HSCT-QC effectively distinguishes the performance of healthy participants from those with mild cognitive impairment or Alzheimer's disease.
conclusionNorms and psychometric data for the HSCT-QC will be highly beneficial for assessing inhibitory control in French-speaking adults in Quebec, Canada.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.